Most clinical research institutions believe their study start-up delays are a technology problem. They aren't. It’s a fragmentation problem, and many technologies ha...

The globalisation of clinical research is accelerating, with a growing share of trials now conducted in emerging markets across Asia, Latin America and Africa. Ventu...

The primary goal of drug safety, or pharmacovigilance, is the detection, assessment, understanding and prevention of adverse effects or any other drug-related proble...

Risk-based quality management (RBQM) is now widely recognised as crucial to improving data quality and clinical trial efficiency. Regulatory backing and increasing c...

Reliable medication intake is a fundamental prerequisite for both therapeutic success and the validity of clinical trial outcomes. Deviations from prescribed regimen...

More than 300 million people worldwide live with a rare disease, representing up to 5.9% of the global population. With over 6,000 distinct conditions, 72% of which ...